EFPIA - NEWSLETTER

EFPIA Newsletter 19 February 2026

News

19 February 2026 A comparative analysis of biopharmaceutical strategies in 10 countries

Biopharma is no longer just a health issue. It is a geopolitical and economic priority. In the global race for innovation,...

Blogs

19 February 2026 The state of caregiving in the EU: Rising to the moment & delivering long-lasting change (Guest...

Europe is entering a decisive decade for care. Across the EU, the demand for long-term care is rising sharply: by 2030,...

13 February 2026 Ensuring equal access to early cancer detection and treatment in Slovenia (Guest blog)

Slovenia marked World Cancer Day with its 6th Strategic Conference Living with Cancer, held at the National Council...

Europe’s Choice: Investing in sustainable health systems

European health and social care systems are under intense pressure.

An ageing population and increased prevalence of non-communicable diseases create huge costs for our economies and societies.

At a time when health budgets are strained, public finances are under pressure, the health workforce crisis is deepening, and Europe faces unprecedented geopolitical challenges, we need to rethink healthcare.

Join us on 21 April to discuss how we can break the cycle, reduce avoidable long-term costs, and improve the lives of European patients.

Register here.

Events

17 MAR 2026

Improving Europe’s water quality - How can the revised UWWTD be implemented fairly... Brussles, Belgium

Join this Euractiv Hybrid Conference to explore how the revised Urban Wastewater Treatment Directive and its EPR scheme...

Learn more →

19 MAR 2026

J&J | The essentials of partnering with a pharma company Utrecht & Virtual

Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation...

Learn more →

What we are reading

Health professionals unite in support of vaccination 17 February 2026 (Vaccines Today)

A broad range of healthcare professionals and student organisations is calling for a concerted effort to protect...

Most new medicines are first tested elsewhere. And that could cost Europe future innovation... 15 February 2026 (EU Perspectives)

Europe is testing plenty of new medicines—but mostly at the later stages. The earliest, most experimental studies,...

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶